Mofebutazone (sodium)

Mofebutazone sodium, a monophenyl analogue of Phenylbutazone (HY-B0230), is an orally active anti-inflammatory agent. Mofebutazone sodium is used in asthma research[1][2].

Product Specifications

CAS Number

[41468-34-2]

UNSPSC

12352005

Target

Drug Derivative

Type

Reference compound

Related Pathways

Others

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/mofebutazone-sodium.html

Smiles

O=C(C1CCCC)[N-]N(C2=CC=CC=C2)C1=O.[Na+]

Molecular Formula

C13H15N2NaO2

Molecular Weight

254.26

References & Citations

[1]F.T. Delbeke, et al. Determination of mofebutazone and its 4-hydroxy metabolite in plasma and urine by high-performance liquid chromatography. Journal of Chromatography A. Volume 369, 1986, Pages 440-444.|[2] Khayyal MT, et al. Tolerability of mofebutazone in asthmatic patients. Int J Clin Pharmacol Res. 1995;15 (4) :145-51.